Skip to main content
. 2016 Apr 28;11(4):e0154482. doi: 10.1371/journal.pone.0154482

Fig 2. Effect of canagliflozin on FABP4 level.

Fig 2

A. Treatment with canagliflozin (100 mg/day) for 12 weeks significantly increased FABP4 level in patients with type 2 diabetes mellitus (n = 39; male/female: 28/11). Open circles: males, closed circles: females. *P = 0.008. B-E. Change in FABP4 level was positively correlated with changes in levels of fasting glucose (B), HbA1c (C) and noradrenaline (D) but was not significantly correlated with change in waist circumference (E).